4.6 Article

Discovery, Structure-Activity Relationship and In Vitro Anticancer Activity of Small-Molecule Inhibitors of the Protein-Protein Interactions between AF9/ENL and AF4 or DOT1L

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth

Xin Li et al.

Summary: This study designed and synthesized compounds that can degrade ENL, a protein involved in MLL1-rearranged leukemia and other cancers. Compound 1 efficiently degraded ENL, suppressed malignant gene signatures, selectively inhibited cell proliferation of leukemia and cancer cells, and induced cell differentiation and apoptosis. It also showed significant antitumor activity in a mouse model of MLL1-rearranged leukemia and could degrade mutant ENL in Wilms tumor.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Article Chemistry, Medicinal

Design, Synthesis, and Biological Evaluations of DOT1L Peptide Mimetics Targeting the Protein-Protein Interactions between DOT1L and MLL-AF9/MLL-ENL

Yinan Yuan et al.

Summary: This study demonstrates that peptide mimetics can selectively inhibit the growth of leukemia cells containing MLL fusion proteins by disrupting the protein-protein interactions between DOT1L and MLL fusion proteins. The most potent compound showed comparable anticancer activities to a clinical stage enzymatic inhibitor and could effectively suppress the methylation of H3K79 at MLL fusion proteins targeted genes.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease

Shenyou Nie et al.

Summary: A novel series of compounds have been discovered as potent inhibitors of the Zika virus protease, with the most effective ones also showing inhibitory effects on dengue and West Nile virus. The most potent compounds were able to strongly inhibit Zika virus replication in cells.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Oncology

De novo acute myeloid leukemia: A population- based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017

Koji Sasaki et al.

Summary: In a population-based study using Surveillance, Epidemiology, and End Results data, the outcomes of patients with acute myeloid leukemia (AML) have shown incremental improvement over time. With the introduction of targeted therapies and optimizations in supportive care, survival rates are expected to continue improving, especially among older patients.

CANCER (2021)

Review Oncology

Structure, function and inhibition of critical protein-protein interactions involving mixed lineage leukemia 1 and its fusion oncoproteins

Xin Li et al.

Summary: MLL1 is a critical transcription factor essential for gene regulation during embryonic development and hematopoiesis, with dysregulation leading to leukemia. Targeted therapies against oncogenic fusion MLL1 are needed, with studies focused on protein-protein interactions for potential therapeutic interventions.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Medicine, Research & Experimental

Small-molecule inhibitor of AF9/ENL-DOT1L/AF4/AFF4 interactions suppresses malignant gene expression and tumor growth

Fangrui Wu et al.

Summary: Chromosome translocations involving MLL gene lead to poor-prognosis acute leukemia. Fusion of MLL with transcription cofactors AF4, AF9, or ENL plays a key role in MLL-rearranged leukemia, with AF9/ENL-DOT1L/AF4/AFF4 interactions identified as a potential drug target. Compound-1, a novel inhibitor of these interactions, shows promising antitumor activity and may serve as a pharmacological lead for further drug development in leukemia treatment.

THERANOSTICS (2021)

Article Oncology

The MLL recombinome of acute leukemias in 2017

C. Meyer et al.

LEUKEMIA (2018)

Review Pediatrics

MLL-Rearranged Leukemias-An Update on Science and Clinical Approaches

Amanda C. Winters et al.

FRONTIERS IN PEDIATRICS (2017)

Review Medical Laboratory Technology

Systematic Classification of Mixed-Lineage Leukemia Fusion Partners Predicts Additional Cancer Pathways

Rolf Marschalek

ANNALS OF LABORATORY MEDICINE (2016)

Review Oncology

MYC, Metabolism, and Cancer

Zachary E. Stine et al.

CANCER DISCOVERY (2015)

Review Oncology

In focus: MLL-rearranged leukemia

J. de Boer et al.

LEUKEMIA (2013)

Review Biochemistry & Molecular Biology

MYC on the Path to Cancer

Chi V. Dang

Article Oncology

c-Myc and Cancer Metabolism

Donald M. Miller et al.

CLINICAL CANCER RESEARCH (2012)

Review Hematology

11q23/MLL Acute Leukemia : Update of Clinical Aspects

Hayato Tamai et al.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2010)

Review Oncology

MLL fusions Pathways to leukemia

Han Liu et al.

CANCER BIOLOGY & THERAPY (2009)

Article Oncology

H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias

Andrei V. Krivtsov et al.

CANCER CELL (2008)

Review Oncology

MLL translocations, histone modifications and leukaemia stem-cell development

Andrei V. Krivtsov et al.

NATURE REVIEWS CANCER (2007)

Article Biochemistry & Molecular Biology

Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization

BB Zeisig et al.

MOLECULAR AND CELLULAR BIOLOGY (2004)